Moonlight AI Sàrl

In the era of personalized Hematology and Oncology, the administration of targeted therapies largely depends on the diagnostics of genomic biomarkers. Moonlight AI lowers the barrier to predictive genomic information by applying computer vision (AI) to scanned images from routinely collected blood or cytology smears. Our approach does not rely on expensive, slow and manual laboratory sequencing services that are often outsourced by diagnostics labs. Instead, we aim to bring new diagnostic capabilities in-house for our customers while reducing the number of non-reimbursed negative results, a particular pain point for in-patient cases. Our solutions will not only empower diagnostic labs to fulfill testing guidelines, but also enable patients around the world to access the right treatment.